Introduction
Several epilepsies such as malignant migrating partial seizures of infancy (MMPSI) and autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) are caused by mutations in the sodiumactivated potassium channel named KCNT1 [1] . Together with their role in epileptic encephalopathies such as MMPSI, KCNT1 mutations are involved in intellectual disability [1] . This report highlights a new phenotypic spectrum consisting of temporal lobe epilepsy (TLE), cerebellar ataxia, and intellectual disability associated with KCNT1 channel mutations in two siblings.
Case report
Two siblings (the male aged 30 years, the female 25 years) were admitted to our tertiary epilepsy center because of seizures of TLE semiology with onset in early adulthood (the female at 18 years, the male 25 years). Neurological examination revealed cerebellar ataxia (Supplementary Video S1A and B in the online version at DOI: 10.1016/j.seizure.2016.12.018), bilateral horizontal nystagmus in both siblings. The male also showed partial color blindness, and high-tone hardness of hearing. Both siblings displayed intellectual disability starting in childhood. Furthermore, the female has suffered from drop attacks since the year she was first admitted to our hospital. We detected syncopes of vasovagal origin by administering an EEG, ECG and Schellong test. MRI revealed beginning hippocampal sclerosis and amygdala enlargement in both subjects (female: Fig. 1A -C, male: Fig. 1D-F Cerebrospinal fluid (CSF) analysis including analysis of specific autoantibodies was normal in both subjects. These results suggest temporal lobe epilepsy in both subjects due to concordant EEG and MRI findings. Genetic analysis of the two siblings' family was done, and the DNA coding sections of the index male patient were subjected to whole exome sequencing. In a search for rare variants potentially associated with epilepsy we detected the heterozygote sequence alteration c.1694G>A; p.Arg565His in Exon 17 of the KCNT1 gene. In all family members the section on chromosome 9 containing the KCNT1 mutation was amplified via PCR. Subsequent sequencing of the amplified DNA was done according to Sanger (Fig. 2A) . In two of three siblings and their mother we also detected the p.Arg565His mutation. This mutation leads to an exchange of an in vertebrates conserved amino acid in the cytoplasmatic C-terminal-domain of the sodium-activated potassium channel subunit K Ca4.1 . (The amino acid sequence alignment of the KCNT1 mutation showing the conservation of arginine 565 in vertebrates is depicted in Supplementary Table S1 in the online version at DOI: 10.1016/j.seizure.2016.12.018). This mutation is a rare variant, since only 5 out of 119672 exomes have been reported to harbor this variant (http://exac.broadinstitute.org). Dominant mutations of this subunit have been previously associated with ADNFLE and infantile epileptic encephalopathy of the type 14. Our two siblings showed the aforementioned phenotype with TLE, intellectual disability, and cerebellar ataxia, whereas the mother with the same mutation did not exhibit any phenotype (the family's pedigree is demonstrated in Fig. 2B ). Unfortunately, we acquired no EEG or MRI data from the mother. However, she suffered no mental retardation, reported no seizures, and presented no other symptoms (such as a disturbed equilibrium state), thus we assume her MRI and EEG would have been normal. The father and the siblings' brother are also healthy and do not feature the KCNT1 mutation (Fig. 2B ).
Discussion
We report a novel phenotype with TLE, cerebellar ataxia, and intellectual disability with early-adulthood onset being associated with a rare mutation in the KCNT1 channel. It is presently unknown whether the reported sequence alteration of KCNT1 leads to a functional disturbance in the potassium channel causing this phenotype, but the rare occurrence of this variant and the good conservation of this amino acid in vertebrates suggest a potential pathogenic relevance. However, as not all mutation carriers display this phenotype, the mutation may be not causally related to it. But, pathogenic epilepsy-associated mutations often exhibit incomplete penetrance, which seems to argue in favor of a causal relationship between geno-and phenotype in our patients. The siblings' mother might have a KCNT1 mosaic mutation that was not detected as we did not employ next-generation sequencing for genetic analysis. However, we do not suspect a KCNT1 mosaicism in addition to the heterozygote KCNT1 mutation, but rather reduced penetrance of the heterozygote KCNT1 mutation being responsible for the mother's healthy phenotype.
The amino acid alignment of KCNT1 indicates strongly conserved arginine 565 in vertebrates (Supplementary Table S1 in the online version at DOI: 10.1016/j.seizure.2016.12.018). However, different prediction programs resulted in highly different scores regarding the pathogenicity of the p.R565H mutation. While SIFT (http://sift. jcvi.org/, score = 0.11) and PolyPhen (http://genetics.bwh.harvard. edu/pph2/, score = 0.056) predicted rather benign consequences of the reported amino acid exchange, MutationTaster (www.mutationtaster.org/, score = 'disease causing') and the CADD score (http://cadd.gs.washington.edu/, PHRED score = 23.6) indicated potential pathogenicity. Additional functional studies on the mutated KCNT1 channel will thus be required to determine the pathogenicity of this particular mutation.
The KCNT1 mutation can cause an enhanced channel activity generated by the raised capacity of sodium binding [2] . Such increased activation might trigger a prolonged hyperpolarization, thereby upsetting the balance between excitation and inhibition, leading to seizures [1, 3] . Bearing the expression of KCNT1 channels in the cerebellum, frontal cortex, and hippocampus [4] in mind, a KCNT1 mutation involving a potential channel malfunction is likely to cause a phenotypic spectrum encompassing cerebellar ataxia, intellectual disability, and TLE.
Taken together, our report highlights the heterozygote sequence alteration (c.1694G>A; p.Arg565His) in Exon 17 of the KCNT1 as a novel, incompletely penetrant mutation being associated with the novel phenotype of mesial TLE, cerebellar syndrome and intellectual disability.
